Business

Same Store Silliness (WMT)(TGT)(CC)(COST)

No one is likely to be happy with all of the same-store sales coming from the big retailers.Wal-mart (WMT) said its sales in February would be up 1% to 2%. ...
Read Full Story »

24/7 Wall St. 2007 Break-Up Values: Anheuser-Busch $56 (Current Price $50.25)

By Ryan Barnes. Edited By Douglas A. McIntyreAnheuser-Busch (BUD) – Price $50.25; Break-up Value $56 Anheuser-Busch has already won the battle to be the largest beer company in the world, ...
Read Full Story »

Record Industry Spits Back At Apple

Don't start a fight you can't finish. The music industry did not capitulate to Apple's (AAPL) suggestion that it allow music to be downloaded without digital rights management. It countered ...
Read Full Story »

Media Digest 2/8/2007 Reuters, WSJ, NYTimes, Barron’s, FT

According to Reuters Imperial Tobacco (ITY) will by US tobacco company CBHC for $1.9 billion.Reuters writes that Unilever (UN) topped forecasts with an increase in profit of 27%.Reuters reports that ...
Read Full Story »

Wednesday’s Top Biotech and Medical Stocks

From BioHealth InvestorBiotechnologyDYAX CORP [DYAX] +9.51% FERMAVIR PHARMACEUTL [FMVR.OB] +8.57% ZIOPHARM ONCOLOGY IN [ZIOP] +7.30% ALNYLAM PHARMACEUT [ALNY] +6.75% GENITOPE CORPORATION [GTOP] +5.85% Diagnostic SubstancesEPICEPT CORPORATION [EPCT] +11.76% GENELABS TECH ...
Read Full Story »

Federal Funding Constraints Forces Elimination of Cancer Trials

by H.S. AyoubBioHealth Investor.comDue to federal budget constraints some 3000 patients could possibly be prevented from taking part in cancer trials nationwide, according to Robert L. Comis, president of the ...
Read Full Story »

Follow Along with Dr. Frost and Invest in Continucare

One strategy that I like to follow when looking at smaller capped stocks is to keep an eye on company insiders, especially those whose investing history is almost perfect.One such ...
Read Full Story »

Cramer Interviewed Celgene’s CEO

Cramer interviewed the CEO (Robert Hugin) of Celgene (CELG-NASDAQ), one name he has been very positive on before.  Cramer said many on the street think they are a one-trick pony ...
Read Full Story »

Cramer Pans Crocs Long-Term But Likes It Short-Term

On tonight’s MAD MONEY on CNBC, Cramer was on a back-to-school tour at University of Virginia with a couple of stock picks.  He thinks the two most exciting stocks in ...
Read Full Story »

Cramer Thinks Under Armour May Be the Next Nike

On tonight’s MAD MONEY on CNBC, Cramer was on a back-to-school tour at University of Virginia with a couple of stock picks.  He thinks the two most exciting stocks in ...
Read Full Story »

What to Think on Riverbed Technology

Riverbed posted $0.03 EPS non-GAAP (loss on GAAP) and revenues were $33.8 million.  This was the first profitable non-GAAP quarter and it added 300 customers, so it appears to have ...
Read Full Story »

Disney, The Magic Kingdom Indeed

Disney (DIS) reported strong earnings for Q4. Excluding non-operating items, EPS rose 43% to $.50. Revenue rose 10% to $9.7 billion.Operating income at the company's studio unit went from $128 ...
Read Full Story »

Cramer’s Less Followed Picks on the Road

On today's STOP TRADING segment on CNBC, Jim Cramer was on the road on a back-to-school special at UVA and he was dismissing the "drop" today as almost nothing.  On ...
Read Full Story »

Jim Cramer Panning ETF’s

Cramer did not have any direct stock picks here today, although you should read oe watch his take on ETF's.  Jim Cramer was discussing ETF's on a pre-recorded Wall Street ...
Read Full Story »

3SBio IPO: Chinese Biotech Success

3SBio Inc. (SSRX-NASDAQ) opened at a premium to its pricing out of the chute today.  The company priced 7.7 million ADR shares at $16.00, and the first print was $17.50.  ...
Read Full Story »